Navigation Links
Prodigy Generics and eVenus Announce the Launch of Oncology Injectable Irinotecan.
Date:5/22/2012

AUSTIN, Texas, May 22, 2012 /PRNewswire/ -- Prodigy Generics, a division of Prodigy Health Supplier Corporation (PHS), has launched injectable irinotecan. Irinotecan is the generic equivalent of the branded drug Camptosar by Pfizer.

Prodigy partnered with eVenus Pharmaceutical Laboratories to develop a portfolio of oncology products. Irinotecan is the first of several ANDAs being developed through the partnership that will add consistent supply and exceptional value to the U.S. injectable market, which has experienced record levels of shortages in the last year.

Irinotecan is indicated for use in the treatment of cancer, primarily colon cancer. It's used in the FOLFIRI chemotherapy regimen consisting of infusional 5-fluorouracil, leucovorin, and irinotecan. Irinotecan is available in 2ML (20 MG per ML) and 5ML (20 MG per ML).

"This launch represents an important milestone for Prodigy. Irinotecan is a drug that was on the FDA drug shortage list in the last year and is a great addition to our expanding generic drug pipeline. We could not be more excited about our partnership with eVenus to add consistent supply to the market," states Jon Houssian, President of Prodigy Generics.

Prodigy Health Supplier Corporation (PHS) was established in 2001 and is based in Austin, Texas. Since inception PHS has been a consistent and dependable supplier in the bio-pharmaceutical industry and has grown into one of the leading suppliers of plasma derivatives and injectables in the United States.

eVenus Pharmaceutical Laboratories Inc., a wholly owned subsidiary of Jiangsu Hengrui Medicine Co, Ltd., was established in the United States in 2009. The company, located in Cranbury, New Jersey, is based on a development and manufacturing history that spans over 40 years.


'/>"/>
SOURCE Prodigy Health Supplier Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Charlotte Business Journal Honors Prodigy Diabetes Care, LLC With Fast 50 Award
2. Prodigy Diabetes Care, LLC Sponsors First Manufacturing Makes It Real Tour
3. Brand Drug Copay Coupons Undermine Generics, Raise Health Costs by $1.8 Billion in Pennsylvania
4. Brand Drug Copay Coupons Undermine Generics, Raise Health Costs by $617 Million in Wisconsin
5. Brand Drug Copay Coupons Undermine Generics, Raise Health Costs by $1.1 Billion in North Carolina
6. Brand Drug Copay Coupons Undermine Generics, Raise Health Costs by $2.3 Billion in New York
7. Brand Drug Copay Coupons Undermine Generics, Raise Health Costs by $681 Million in Missouri
8. Brand Drug Copay Coupons Undermine Generics, Raise Health Costs by $1.4 Billion in Illinois
9. Brand Drug Copay Coupons Undermine Generics, Raise Health Costs by $1 Billion in New Jersey
10. Brand Drug Copay Coupons Undermine Generics, Raise Health Costs by $1.1 Billion in Michigan
11. Brand Drug Copay Coupons Undermine Generics, Raise Health Costs by $308 Million in Arkansas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... Cryoablation, Electrical, Endometrial Hydrothermal, Laser/Light, Microwave, Radiofrequency, Ultrasound, Cardiovascular, Gynaecology, ... expected to grow at a CAGR of 9.4% from 2017-2022 and ... at a CAGR of 9.5% from 2017 to 2027. The market ... ... benefit you Read on to discover how you can exploit ...
(Date:2/17/2017)... 2017 Arvinas LLC, a private biotechnology company ... degradation, today announced the presentation of new preclinical data ... poster session at the American Society of Clinical Oncology ... Orlando, FL. "The new ... the potential of PROTACs to drive durable and robust ...
(Date:2/17/2017)... and Markets has announced the addition of the "Pharmaceutical Contract Manufacturing ... ... the US, Canada , Japan , ... of World. Annual estimates and forecasts are provided for the period 2015 ... Market data and analytics are derived from primary and secondary research. ...
Breaking Medicine Technology:
(Date:2/17/2017)... FL (PRWEB) , ... February 17, 2017 , ... ... software tools that allow for the electronic prescribing of controlled and non-controlled substances ... , Ninety percent of pharmacies in the United States now accept electronic prescriptions, ...
(Date:2/17/2017)... ... February 17, 2017 , ... Empowering each person's mental functions, ... each and every seminar, session and class she offers. At the International ... which help energize creativity, focus mental functions, enhance athletic focus and skill sets, ...
(Date:2/17/2017)... , ... February 17, 2017 , ... ... the HIMSS17 Conference & Exhibition in Orlando, Fla., February 19-23. Visitors to the ... the most widely used electronic patient signatures solution in healthcare . ...
(Date:2/17/2017)... ... February 17, 2017 , ... Pharmica Consulting attended ... all facets of clinical trial planning and management. Pharmica discussed the importance of ... In addition, attendees stopping by Pharmica’s booth were able to demo its cloud-based ...
(Date:2/17/2017)... ... 17, 2017 , ... Like most hospitals across the nation, Onslow Memorial Hospital ... the Hospital Readmission Reduction Program (HRRP), the return of a patient to the hospital ... the nation. While many providers are struggling to leverage limited resources and technology, Onslow ...
Breaking Medicine News(10 mins):